Growth Metrics

Incyte (INCY) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $1.46.

  • Incyte's EPS (Weighted Average and Diluted) rose 5368.42% to $1.46 in Q4 2025 from the same period last year, while for Dec 2025 it was $6.41, marking a year-over-year increase of 310500.0%. This contributed to the annual value of $6.41 for FY2025, which is 417333.33% up from last year.
  • According to the latest figures from Q4 2025, Incyte's EPS (Weighted Average and Diluted) is $1.46, which was up 5368.42% from $2.11 recorded in Q3 2025.
  • Incyte's 5-year EPS (Weighted Average and Diluted) high stood at $2.54 for Q4 2021, and its period low was -$2.04 during Q2 2024.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.76 (2023), whereas its average is $0.75.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 127142.86% in 2021, then plummeted by 32666.67% in 2024.
  • Over the past 5 years, Incyte's EPS (Weighted Average and Diluted) (Quarter) stood at $2.54 in 2021, then plummeted by 95.28% to $0.12 in 2022, then surged by 641.67% to $0.89 in 2023, then rose by 6.74% to $0.95 in 2024, then soared by 53.68% to $1.46 in 2025.
  • Its last three reported values are $1.46 in Q4 2025, $2.11 for Q3 2025, and $2.04 during Q2 2025.